Clinical trials
Phase 3 Dyslipidemias trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 7 |
| 2007 | 2 |
| 2008 | 1 |
| 2013 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2021 | 3 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Unknown status | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Takeda | 7 |
| EMS | 3 |
| Novartis Pharmaceuticals | 3 |
| Amgen | 2 |
| Kastle Therapeutics, LLC | 2 |
| Ache Laboratorios Farmaceuticos S.A. | 1 |
| Instituto de Cardiologia do Rio Grande do Sul | 1 |
| Kowa Research Institute, Inc. | 1 |
| Sanofi | 1 |
| Torrent Pharmaceuticals Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 22 |
| Diabetes Mellitus | 8 |
| Diabetes Mellitus, Type 2 | 8 |
| Glucose Metabolism Disorders | 7 |
| Hypercholesterolemia | 7 |
| Hyperlipidemias | 6 |
| Hyperlipoproteinemia Type II | 3 |
| Cardiovascular Diseases | 2 |
| Congenital Abnormalities | 2 |
| Genetic Diseases, Inborn | 2 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.